Moreover, HBx contributes to the inhibition of the Gld2/miR-122 pathway and subsequent overexpression of CAT-1, thereby increasing cell proliferation and invasion in HBV-related HCC. The gene discussed is SLC7A1; the disease is hepatocellular carcinoma.